[PDF][PDF] Formulation design and optimization of aceclofenac tablets (100 mg) using central composite design with response surface methodology
The aim of study is to develop and optimize aceclofenac tablets using central composite de-
sign with response surface methodology (RSM). Immediate-release aceclofenac tablets …
sign with response surface methodology (RSM). Immediate-release aceclofenac tablets …
[PDF][PDF] Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies
Simple and cost effective study consisting of three steps, comparison of micromeritic
properties of different blends ie placebo without API and Nimesulide containing, Use of …
properties of different blends ie placebo without API and Nimesulide containing, Use of …
Development of in vitro - in vivo correlations for newly optimized Nimesulide formulations
Use of the human volunteers in bioequivalence studies is being discouraged by the Food
and drug administration after the introduction of biowaiver approaches. In-vitro in-vivo …
and drug administration after the introduction of biowaiver approaches. In-vitro in-vivo …
[PDF][PDF] Comparative studies of ciprofloxacin 250 mg tablets available in Pakistani market
A simple and cost effective comparative study consisting of quality control assessment of 12
brands of ciprofloxacin 250 mg tablets having price range of 0.486 to 2.823$ per pack and …
brands of ciprofloxacin 250 mg tablets having price range of 0.486 to 2.823$ per pack and …
Influence of different viscosity grade cellulose-based polymers on the development of valsartan controlled release tablets
This work is based on formulating and optimizing controlled release (CR) valsartan (160 mg)
tablets using different viscosity grades of the cellulosic polymer. The objective was to …
tablets using different viscosity grades of the cellulosic polymer. The objective was to …
[PDF][PDF] Development and optimization of fast dispersible Flurbiprofen 100mg tablets by central composite design
The aim of the present study was to develop and optimize fast dispersible flurbiprofen tablets
using central composite design (Design Expert®). Nine different formulations (F1-F9) were …
using central composite design (Design Expert®). Nine different formulations (F1-F9) were …
Development and in-vitro evaluation of once daily tablet dosage form of loxoprofen sodium
Methods: Eudragit RS-100, hydroxylpropyl methylcellulose (HPMC) and pectin were used
as release retarding polymers. All the formulations were prepared by direct compression …
as release retarding polymers. All the formulations were prepared by direct compression …
[PDF][PDF] Pharmaceutical Surveillance Study of Moxifloxacin Formulations: Therapeutic Perspective in Terms of Quality and Efficacy
Several benefits have been presented by the solid oral dosage forms such as high
production yield, consistent quality attributes safe and convenient administration etc. Orally …
production yield, consistent quality attributes safe and convenient administration etc. Orally …
[PDF][PDF] Optimization of empagliflozin immediate release tablets (10 mg) using central composite rotatable design with response surface methodology.
AM Hanif, R Bushra, W Iffat, S Ghayas… - Pakistan Journal of …, 2021 - researchgate.net
Empagliflozin is a selective inhibitor of sodium glucose co-transporter II, given as mono
therapy or an add-on treatment to reduce the glycated hemoglobin levels in type 2 diabetes …
therapy or an add-on treatment to reduce the glycated hemoglobin levels in type 2 diabetes …
[PDF][PDF] Development and optimization of diclofenac potassium tablets using central composite design and dissolution profile comparison
The objective of the present study was to develop and optimize diclofenac potassium
immedi-ate release tablets using response surface methodology (RSM). A four-factor, five …
immedi-ate release tablets using response surface methodology (RSM). A four-factor, five …